105 related articles for article (PubMed ID: 22517720)
1. Imatinib-induced anasarca without heart failure: capillary leakage?
Sendur MA; Aksoy S; Civelek B; Zengin N
J BUON; 2012; 17(1):188-9. PubMed ID: 22517720
[No Abstract] [Full Text] [Related]
2. Facial hyperpigmentation during imatinib therapy for gastrointestinal stromal tumor.
Hamza I; Gaies E; Kastalli S; Daghfous R; El Aidli S
Therapie; 2014; 69(3):245-7. PubMed ID: 24934821
[TBL] [Abstract][Full Text] [Related]
3. Osteonecrosis of the tibia associated with imatinib in metastatic GI stromal tumor.
Yeh CN; Fu CJ; Yen TC; Chiang KC; Jan YY; Chen MF
J Clin Oncol; 2013 Jun; 31(16):e248-50. PubMed ID: 23569321
[No Abstract] [Full Text] [Related]
4. Imatinib-induced avascular necrosis of femur in childhood chronic myeloid leukemia.
Nataraj V; Kandasamy D; Bakhshi S
Pediatr Hematol Oncol; 2014 Apr; 31(3):268-70. PubMed ID: 24383853
[No Abstract] [Full Text] [Related]
5. Imatinib induced pyoderma gangrenosum.
Pinato DJ; Sharma R
J Postgrad Med; 2013; 59(3):244-5. PubMed ID: 24029213
[No Abstract] [Full Text] [Related]
6. Transient respiratory failure possibly associated to imatinib.
Lengerke C; Brümmendorf T; Herrlinger U; Horger M; Kanz L; Hartmann JT
Invest New Drugs; 2005 Mar; 23(2):137-8. PubMed ID: 15744589
[No Abstract] [Full Text] [Related]
7. Lichenoid drug eruption with hyperpigmentation caused by imatinib mesylate.
Kagimoto Y; Mizuashi M; Kikuchi K; Aiba S
Int J Dermatol; 2014 Mar; 53(3):e161-2. PubMed ID: 23786260
[No Abstract] [Full Text] [Related]
8. Imatinib-induced bone edema: case report and review of literature.
dos Santos LV; Lima JP; Abdalla KC; Bragagnoli AC; Santos FA; dos Anjos Jácome A; Porto FE
J Natl Compr Canc Netw; 2013 Oct; 11(10):1187-91. PubMed ID: 24142819
[TBL] [Abstract][Full Text] [Related]
9. Hair graying and loss induced by imatinib mesylate.
Yun SK; Song KH; Hwang SR; Kim HU; Lee NR; Park J
J Dermatol; 2014 Jan; 41(1):107-8. PubMed ID: 24354806
[No Abstract] [Full Text] [Related]
10. Imatinib mesylate-induced acute hepatitis in a patient treated for gastrointestinal stromal tumour.
Pariente A; Etcharry F; Cales V; Laborde Y; Ferrari S; Biour M
Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):785-7. PubMed ID: 16772838
[TBL] [Abstract][Full Text] [Related]
11. Intolerance to imatinib in gastrointestinal stromal tumors: a case report and a review of literature.
Akasbi Y; Arifi S; Brahmi SA; El Mrabet FZ; Mellas N; Mernisi FZ; El Mesbahi O
J Gastrointest Cancer; 2014 Dec; 45 Suppl 1():71-3. PubMed ID: 24006243
[No Abstract] [Full Text] [Related]
12. Non-islet-cell tumor induced hypoglycemia in patients with advanced gastrointestinal stromal tumor possibly worsened by imatinib.
Hamberg P; de Jong FA; Boonstra JG; van Doorn J; Verweij J; Sleijfer S
J Clin Oncol; 2006 Jun; 24(18):e30-1. PubMed ID: 16782905
[No Abstract] [Full Text] [Related]
13. Gastric antral vascular ectasia in a patient with GIST after treatment with imatinib: case report and literature review.
Saad Aldin E; Mourad F; Tfayli A
Jpn J Clin Oncol; 2012 May; 42(5):447-50. PubMed ID: 22422898
[TBL] [Abstract][Full Text] [Related]
14. Severe dental erosion associated with imatinib mesylate therapy.
Kyriazoglou A; Christopoulos C
Acta Oncol; 2014 Jul; 53(7):988-90. PubMed ID: 24446745
[No Abstract] [Full Text] [Related]
15. Imatinib-induced pathologic changes including bile duct dilatation in hepatic metastases of gastrointestinal stromal tumor: case report and review of literature.
Lee YS; Lee SH; Choi YJ; Jung ES
J Cancer Res Ther; 2014; 10(3):763-6. PubMed ID: 25313780
[TBL] [Abstract][Full Text] [Related]
16. Imatinib treatment of metastatic GIST: don't stop (believing).
Heinrich MC
Lancet Oncol; 2010 Oct; 11(10):910-1. PubMed ID: 20864404
[No Abstract] [Full Text] [Related]
17. Acne rosacea associated imatinib mesylate in a gastrointestinal stromal tumor patient.
Demirci U; Coskun U; Erdem O; Ozturk B; Bilge Yilmaz I; Benekli M; Buyukberber S
J Oncol Pharm Pract; 2011 Sep; 17(3):285-7. PubMed ID: 20551113
[TBL] [Abstract][Full Text] [Related]
18. Early onset imatinib mesylate-induced hepatotoxicity in a patient with gastrointestinal stromal tumors.
Yachoui R
Am J Ther; 2014; 21(5):e148-50. PubMed ID: 23567788
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B viral reactivation secondary to imatinib treatment in a patient with gastrointestinal stromal tumor.
Walker EJ; Simko JP; Ko AH
Anticancer Res; 2014 Jul; 34(7):3629-34. PubMed ID: 24982379
[TBL] [Abstract][Full Text] [Related]
20. An acute hepatitis resembling autoimmune hepatitis occurring during imatinib therapy in a gastrointestinal stromal tumor patient.
Aliberti S; Grignani G; Allione P; Fizzotti M; Galatola G; Pisacane A; Aglietta M
Am J Clin Oncol; 2009 Dec; 32(6):640-1. PubMed ID: 19955903
[No Abstract] [Full Text] [Related]
[Next] [New Search]
